Bard Pushes Back Expected Launch Date For AF Ablation Catheter
This article was originally published in The Gray Sheet
Executive Summary
Stringent FDA clinical trial requirements have caused C.R. Bard to push back the U.S. launch timeline for its RF mesh ablation catheter for atrial fibrillation to late 2008 or 2009. The company had hoped to release the product almost one year sooner